Skip to main content
. 2022 Nov 4;17(11):e0273781. doi: 10.1371/journal.pone.0273781

Fig 2. Sensitivity analysis of the expected value of prenatal screening for toxoplasmosis vs no screening, according to the annual incidence of primary maternal infection.

Fig 2